Notably, serum adiponectin levels decline in the obese, and low levels of the high molecular adiponectin complexes contribute to metabolic diseases such as insulin resistance and non-alcoholic fatty liver disease [42,91,92]. Here, ADIPOQ is linked to Insulin resistance.